|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Nephrology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
2 Department of Medicine, University of Chicago, Chicago, IL, USA
* To whom correspondence should be addressed. E-mail: Lieske.John{at}mayo.edu.
Attachment of newly formed crystals to renal tubular epithelial cells appears to be a critical step in the development of kidney stones. The current study was undertaken to identify autocrine factors released from renal epithelial cells into the culture medium that inhibit adhesion of calcium oxalate crystals to the cell surface. A 39-kDa glycoprotein that is constitutively secreted by renal cells was purified by gel filtration chromatography. Amino acid microsequencing revealed that it is novel, and not structurally related to known inhibitors of calcium oxalate crystallization. Hence it was named Crystal Adhesion Inhibitor, or CAI. Immunoreactive CAI was detected in diverse rat tissues including kidney, heart, pancreas, liver, and testis. Immunohistochemistry revealed that CAI is present in renal cell cytosol, and is also on the plasma membrane. Importantly, CAI is present in normal human urine, from which it can be purified using calcium oxalate monohydrate crystal affinity chromatography. CAI could be an important defense against crystal attachment to tubular cells and the subsequent development of renal stones in vivo.
This article has been cited by other articles:
![]() |
M. L. Merchant, T. D. Cummins, D. W. Wilkey, S. A. Salyer, D. W. Powell, J. B. Klein, and E. D. Lederer Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1254 - F1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Grover, L. A. Thurgood, and R. L. Ryall Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1396 - F1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stankus, E. Worcester, M. Hammes, and F. L. Coe Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones Nephrol. Dial. Transplant., March 1, 2006; 21(3): 701 - 706. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |